Drug-labels.com

Mdk-Nitisinone: Uses, Side Effects and Dosage

Updated:
Facts
Status:
Prescription (Rx)
Strength:
10 mg, 2 mg, 5 mg, 20 mg
Active ingredient:
ATC code:

Patient Medication Information: uses, side effects, how to take - Mdk-Nitisinone

What is MDK-Nitisinone used for?

MDK-Nitisinone is used for the treatment of hereditary tyrosinemia type 1 (HT-1), in addition to limiting the amount of tyrosine and phenylalanine in the diet.

How does MDK-Nitisinone work?

MDK-Nitisinone stops the build-up of toxic substances which cause the severe liver and kidney problems in patients with HT-1. By doing that, it also prevents the porphyric crises associated with HT-1.

What are the ingredients in MDK-Nitisinone?

Medicinal ingredient: nitisinone.

Non-medicinal ingredients: corn starch, gelatine, iron oxide, shellac glaze, titanium dioxide.

MDK-Nitisinone comes in the following dosage forms:

Capsules: 2 mg, 5 mg, 10 mg or 20 mg

Do not use MDK-Nitisinone if you:

  • are allergic (hypersensitive) to nitisinone or any of the other ingredients in MDK-

    Nitisinone.

  • are breast-feeding. Do not breast feed while taking MDK-Nitisinone.

To help avoid side effects and ensure proper use, talk to your healthcare professional before you take MDK-Nitisinone. Talk about any health conditions or problems you may have, including if you:

  • are pregnant or planning to become pregnant.

Other warnings you should know about:

Dietary Changes

Taking MDK-Nitisinone can cause high levels of tyrosine in your blood which can be toxic. As a result, while you are taking MDK-Nitisinone you must limit the amount of tyrosine and phenylalanine in your diet. Talk to your healthcare professional about which foods are safe to eat and which foods should be avoided.

Eye Problems

Your healthcare professional will check your eyes before starting treatment with MDK-Nitisinone. If you develop eye problems while taking MDK-Nitisinone, including sensitivity to light, eye pain, redness, swelling or burning, talk to your healthcare professional immediately.

Tell your healthcare professional about all the medicines you take, including any drugs, vitamins, minerals, natural supplements or alternative medicines.

How to take MDK-Nitisinone:

  • MDK-Nitisinone is usually taken twice a day.
  • MDK-Nitisinone can be taken with or without food however, it should always be taken the same way. Therefore, if you start taking MDK-Nitisinone with food, you should always take it with food.

  • For young children, MDK-Nitisinone capsules can be opened and the contents sprinkled into a small amount of water or formula immediately before use.

Usual dose:

Your healthcare professional will tell you how much MDK-Nitisinone to take and when to take it.

Overdose:

If you think you have taken too much MDK-Nitisinone, contact your healthcare professional, hospital emergency department or regional Poison Control Centre immediately, even if there are no symptoms.

Missed Dose:

If you miss a dose by less than 12 hours, take it as soon as you remember.

What are possible side effects from using MDK-Nitisinone?

These are not all the possible side effect you may feel when taking MDK-Nitisinone. If you experience any side effects not listed here, contact your healthcare professional.

MDK-Nitisinone can cause abnormal blood test results. While you are taking MDK-Nitisinone your healthcare professional will decide when to perform blood tests and will interpret the results.

Serious side effects and what to do about them

Symptom / effectTalk to your healthcare professionalStop taking drug and get immediate medical help
Only if severeIn all cases

COMMON

Low Platelets: easy or unusual bruising. Bleeding into the skin causing a rash of pinpoint-sized reddish-purple spots, usually in the lower legs, prolonged bleeding from cuts, bleeding from your gums or nose, blood in urine or stools.

√
Low White Blood Cells: infections, fatigue, weakness, fever, aches and pains, flu-like symptoms.√
Eye Problems: redness, eye discharge, itchy eyes, burning eyes, blurred vision, sensitivity to light, milky or cloudy area on the eye, eye pain, a feeling that there is something in your eye.√

RARE

Skin Problems: dry/cracked/scaly skin, rashes, small flat red bumps, itching that can be severe, blisters, draining fluid and crusting, swelling, burning, tenderness, loss of hair in patches.

√

If you have a troublesome symptom or side effect that is not listed here or becomes bad enough to interfere with your daily activities, talk to your healthcare professional.

Reporting Side Effects

  • You can report any suspected side effects associated with the use of health products to

    Health Canada by:Visiting the Web page on Adverse Reaction Reporting (http://www.hc-sc.gc.ca/dhp-mps/medeff/report-declaration/index-eng.php) for information on how to report online, by mail or by fax; or

  • Calling toll-free at 1-866-234-2345.

NOTE: Contact your healthcare professional if you need information about how to manage your side effects. The Canada Vigilance Program does not provide medical advice.

Storage:

Store refrigerated between 2-8°C.

Opened bottles of 2 mg capsules can be stored for 1 month at room temperature (not above 25°C); then discarded.

Opened bottles of 5, 10 and 20 mg capsules can be stored for 3 months at room temperature (not above 25°C); then discarded.

Keep out of reach and sight of children.

If you want more information about MDK-Nitisinone:

  • Talk to your healthcare professional.
  • Find the full product monograph that is prepared for healthcare professionals and includes this Patient Medication Information by visiting the Health Canada website (https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/drug-product-database.html); the manufacturer’s website www.mendelikabs.com, by calling 1-888-959-9987 or by sending an email to: contact@mendelikabs.com.

Last Revised: November 29, 2017

About this document

Source: Health Canada – Drug Product Database (DPD) and product monographs · DIN (Drug Identification Number): 02457733

Revision date stated in the text: November 29, 2017

Found a mistake? Write to us via the contact page.

The information on this site does not replace the advice of a doctor or pharmacist.

Drug information for Mdk-Nitisinone

Rx or OTC
Prescription (Rx)?
DIN 02457733, 02457717, 02457725, 02470055
Schedule(s) PRESCRIPTION
Active ingredient(s) Nitisinone
Dosage form(s) Capsule
Route(s) of administration Oral
Drug class (WHO ATC)
  1. A Alimentary tract and metabolism drugs
    1. A16 Other alimentary tract and metabolism products
      1. A16A Other alimentary tract and metabolism products
        1. A16AX Various alimentary tract and metabolism products
          1. A16AX04 Nitisinone
Company MENDELIKABS INC
Strengths and forms
DIN Strength Dosage form(s) Current status
02457733 10 MG Capsule Marketed October 15, 2025
02457717 2 MG Capsule Marketed October 20, 2016
02457725 5 MG Capsule Marketed October 20, 2016
02470055 20 MG Capsule Dormant June 24, 2020

Source: Health Canada – Drug Product Database (DPD) and product monographs, data as of November 1, 2026. Data from the Health Canada Drug Product Database, as published there. Not a substitute for the advice of a doctor or pharmacist.